Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076508
Company: TARO
Company: TARO
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | GEL, AUGMENTED;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/02/2003 | ORIG-1 | Approval |
Label is not available on this site. |
BETAMETHASONE DIPROPIONATE
GEL, AUGMENTED;TOPICAL; EQ 0.05% BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | GEL, AUGMENTED;TOPICAL | Prescription | No | AB | 075276 | FOUGERA PHARMS |
BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE | EQ 0.05% BASE | GEL, AUGMENTED;TOPICAL | Prescription | No | AB | 076508 | TARO |